Scalable lipid droplet microarray fabrication, validation, and screening

TL;DR

This paper presents a scalable lipid droplet microarray fabrication method enabling efficient drug screening in cell culture, reducing costs and space requirements for high throughput assays.

Contribution

The authors developed a scalable nanointaglio printing process for lipid droplet arrays, validated their use in cell culture, and demonstrated screening of natural products on miniaturized arrays.

Findings

Arrays can deliver lipophilic and water-soluble compounds effectively.

The method is compatible with multiple cell types.

Arrays enable miniaturized screening in limited space environments.

Abstract

High throughput screening of small molecules and natural products is costly, requiring significant amounts of time, reagents, and operating space. Although microarrays have proven effective in the miniaturization of screening for certain biochemical assays, such as nucleic acid hybridization or antibody binding, they are not widely used for drug discovery in cell culture due to the need for cells to internalize lipophilic drug candidates. Lipid droplet microarrays are a promising solution to this problem as they are capable of delivering lipophilic drugs to cells at dosages comparable to solution delivery. However, the scalablility of the array fabrication, assay validation, and screening steps has limited the utility of this approach. Here we demonstrate a scalable process for lipid droplet array fabrication, assay validation in cell culture, and drug screening. A nanointaglio printing process has been adapted for use with a printing press. The arrays are stabilized for immersion into aqueous solution using a vapor coating process. In addition to delivery of lipophilic compounds, we found that we are also able to encapsulate and deliver a water-soluble compound in this way. The arrays can be functionalized by extracellular matrix proteins such as collagen prior to cell culture as the mechanism for uptake is based on direct contact with the lipid delivery vehicles rather than diffusion of the drug out of the microarray spots. We demonstrate this method for delivery to 3 different cell types and the screening of 90 natural product extracts on a microarray covering an area of less than 0.1 cm2. The arrays are suitable for miniaturized screening, for instance in BSL-3 conditions where space is limited and for applications where cell numbers are limited, such as in functional precision medicine.